Skip to main content
Elsevier

Parkinson's Disease and Related Disorders, Part II

  • 1st Edition, Volume 84 - June 25, 2007
  • Latest edition
  • Authors: William C. Koller, Eldad Melamed
  • Language: English

This volume provides comprehensive information on Parkinson’s disease and related disorders, a group of diseases that are among the most common in the field of neurodegenerative st… Read more

Purchase options

Sorry, this title is not available for purchase in your country/region.

Description

This volume provides comprehensive information on Parkinson’s disease and related disorders, a group of diseases that are among the most common in the field of neurodegenerative study.

Through a high-level presentation of new research regarding these diseases, this handbook will give clinicians and neuroscientists alike a better understanding of the dramatic pharmacological advances made in the management of Parkinson’s disease, and the profound observations that have altered the medical community’s approach to other degenerative disorders of the nervous system.

Practitioners, researchers, and medical personnel will gain exciting insights into recent developments that form the basis for new therapeutic strategies and management protocols for the various neurological disorders that present with Parkinsonism.

Key features

* A comprehensive resource on new advancements in the field of Parkinson’s research and related neurodegenerative diseases* Important information on dramatic pharmacological advances in the management of Parkinson’s disease* A platform to stimulate new research and better understanding of these common and disabling neurological disorders

Readership

Neurologists and research neuroscientists

Table of contents

Section 5: Treatment of Parkinson's diseasePhysical therapy in Parkinson’s disease. Neuroprotection in Parkinson’s disease: clinical trials. Levodopa. Dopamine agonists. Monoamine oxidase A and B inhibitors in Parkinson’s disease. Anticholinergic medications. Antiglutamatergic drugs in the treatment of Parkinson’s disease. Investigational drugs. The importance of patients groups and collaborationSection 6: Complications of therapyMotor and non-motor fluctuations. Levodopa-induced dyskinesias in Parkinson’s disease. Treatment induced mental changes in Parkinson’s disease.Section 7 Surgical treatmentAblative surgery for the treatment of Parkinson’s disease. Deep brain stimulation. Transplantation. Gene therapy approaches for the treatment of Parkinson’s disease.Section 8: Other parkinsonian disease syndromesMultiple system atrophy. Progressive supranuclear palsy. Corticobasal degeneration. Infectious basis to the pathogenesis of Parkinson’s disease. Toxic causes of Parkinson’s disease. Drug induced parkinsonism. Vascular parkinsonism. Old age and Parkinson’s disease. Other degenerative processes. Hydrocephalus and structural lesions. Calcification of the basal ganglia. Trauma and Parkinson’s disease. Psychogenic parkinsonism. Parkinsonism and dystonia. Dementia with Lewy bodies. Myoclonus and parkinsonism.

Product details

  • Edition: 1
  • Latest edition
  • Volume: 84
  • Published: June 25, 2007
  • Language: English

About the authors

WK

William C. Koller

Affiliations and expertise
Department of Neurology, UNC-Chapel Hill, NC, USA

EM

Eldad Melamed

Affiliations and expertise
Department of Neurology, Rabin Medical Center, Petaq Tiqva, Israel

View book on ScienceDirect

Read Parkinson's Disease and Related Disorders, Part II on ScienceDirect